Well a good exercise for the board is to figure out a fair per share price for the Lovenox portion of MNTA assuming Teva were to be approved tomorrow. I value the mL royalties given Teva generic as: Range $210M to 270M Just divide by shares outstanding to get your number - call it $4 to $5. ij